Equities
Health CareMedical Equipment and Services
  • Price (SEK)33.18
  • Today's Change0.34 / 1.04%
  • Shares traded1.34m
  • 1 Year change-11.90%
  • Beta0.5131
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Arjo AB (publ) is a Sweden-based supplier of products, services and solutions for people with reduced mobility and age-related health challenges. The Company’s offering includes products and solutions within the product segments Patient handling, Hygiene, Disinfection, Therapeutic surfaces, Venous Thromboembolism (VTE) prevention and Diagnostics. Additionally, the Company is offering its customers complementing services. The products comprise ceiling lifts, standing and raising aids, slings, floor lifters, among others. Arjo AB (publ) operates in more than 60 countries, which the Company divides into three geographical areas: North America, Western Europe and Rest of the World.

  • Revenue in SEK (TTM)11.18bn
  • Net income in SEK511.00m
  • Incorporated2016
  • Employees6.85k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CellaVision AB737.16m150.21m5.12bn228.0034.066.6626.676.946.306.3030.9132.190.78491.917.263,233,162.0015.9915.3018.4518.2466.9969.0320.3819.982.151,358.860.044110.185.9413.1710.128.0030.458.45
RaySearch Laboratories AB (publ)1.17bn175.06m5.31bn414.0039.118.4412.774.555.105.1034.0923.650.60235.513.293,005,152.009.021.2913.691.8891.0690.5714.972.551.27108.610.370669.0021.1610.26243.060.7648-1.31--
Surgical Science Sweden AB859.83m193.34m7.45bn270.0038.561.6829.628.673.793.7916.8587.190.17691.566.803,307,035.003.984.494.214.7868.6570.0622.4923.753.73--0.000.0010.0168.1424.47--38.57--
Arjo AB (publ)11.18bn511.00m8.35bn6.85k17.501.145.580.74641.881.8841.0528.870.71494.546.781,644,896.003.263.554.625.5543.6444.014.565.410.6263.970.407343.0110.035.976.9010.15-8.8910.35
Revenio Group Oyj1.18bn220.23m8.59bn230.0038.567.3030.567.260.72040.72043.863.810.78344.938.17472,574.1014.6714.3317.0917.9049.2950.7318.7221.131.5134.570.127655.81-0.412525.80-12.1518.7217.676.30
Biotage AB2.13bn257.00m12.10bn675.0047.083.1727.625.693.213.2126.5647.600.43121.597.223,155,786.005.2110.746.0512.7762.6761.4012.0815.751.1543.880.061640.1119.5415.50-8.217.9714.051.30
ChemoMetec A/S633.56m211.70m12.22bn173.0057.7413.9251.1019.297.837.8323.4432.480.61120.7456.972,357,630.0020.4227.9624.4035.1078.8079.5733.4135.023.76--0.0073144.08-8.2218.37-23.7226.649.97-11.81
Data as of Nov 22 2024. Currency figures normalised to Arjo AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

29.88%Per cent of shares held by top holders
HolderShares% Held
Fj�rde AP-fondenas of 30 Apr 202426.03m10.24%
The Vanguard Group, Inc.as of 30 Apr 20248.27m3.25%
Svolder AB (Investment Management)as of 30 Apr 20247.60m2.99%
F�rsta AP-fondenas of 30 Apr 20246.50m2.56%
Dimensional Fund Advisors LPas of 30 Apr 20246.28m2.47%
Norges Bank Investment Managementas of 31 Dec 20235.54m2.18%
Handelsbanken Fonder ABas of 31 Oct 20244.24m1.67%
BlackRock Fund Advisorsas of 30 Apr 20243.89m1.53%
SEB Investment Management ABas of 30 Apr 20243.83m1.51%
E. �hman J :or Fonder ABas of 30 Sep 20243.75m1.48%
More ▼
Data from 29 Feb 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.